Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial

Authors :: R. Olivier
Jérôme Boursier
Fabien Zoulim
Odile Goria
M.D. Gratien
Dominique Larrey
Armando Abergel
Tabassome Simon
P. Mathurin
Alexandra Heurgué-Berlot
Eric Nguyen-Khac
Olivier Chazouillères
L.G. Antonia
F.-H. Admane
N. Gisèle
Christophe Corpechot
Jean-Pierre Bronowicki
Alexandra Rousseau
Anne Minello Franza
C. Silvain
François Habersetzer
O.-H. Isabelle
P. Pascal
R.E. Poupon
V. de Ledinghen
Gaouar Farid
Jean-Pierre Zarski
Source :: Journal of Hepatology. 68:S3-S4
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Transplantation
Reduction (complexity)
medicine.medical_specialty
Bezafibrate
Hepatology
business.industry
Internal medicine
medicine
In patient
business
Gastroenterology
medicine.drug

Full Text Access

Tools